| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Unrealized (gain) on digital assets | NaN | NaN | 77,996,124 | 101,332 |
| Digital asset revenue | NaN | NaN | 6,083,617 | 985,009 |
| Loss on impairment of building | NaN | NaN | NaN | 0 |
| Impairment of goodwill and intangible assets | NaN | NaN | NaN | 0 |
| Net loss from operations | 333,697,446 | -178,924,930 | 66,748,122 | -13,684,209 |
| Depreciation and amortization | 107,479 | 153,578 | 155,092 | 757,758 |
| Unrealized loss on digital assets | 265,305,278 | -86,498,895 | NaN | NaN |
| Realized loss on sale of digital asset | 6,773,418 | NaN | NaN | NaN |
| Digital asset revenue | 3,506,432 | 11,227,130 | NaN | NaN |
| Gain on the sale of vitamedica and income from discontinued operations | NaN | NaN | NaN | 0 |
| Digital asset revenue conversion to usd | 2,066,474 | 4,771,563 | NaN | NaN |
| Loss on the sale of new england technology | NaN | NaN | NaN | 0 |
| Loss on digital asset revenue conversion to usd | 1,887,472 | 341,599 | NaN | NaN |
| Amortization of loan costs | 2,701,917 | 0 | 0 | 30,462 |
| Amortization of consideration discount | 0 | NaN | NaN | 0 |
| Loss on disposal of property and equipment | -225,466 | NaN | NaN | NaN |
| Gain on extinguishment of debt | 1,330,865 | NaN | NaN | NaN |
| Inventory write-off for amazon inventory | 0 | NaN | NaN | 748,874 |
| Loss on sale of assets related to relocation of facility | NaN | NaN | NaN | 0 |
| Gain on sale of interactive offers | NaN | NaN | NaN | 0 |
| Loss on the disposal of assets | NaN | NaN | NaN | -10,743 |
| Provision for credit losses for amazon receivable | -229 | NaN | 229 | 933,950 |
| Reduction of acquisition payable | 0 | NaN | NaN | 152,500 |
| Issuance of stock for services | NaN | NaN | NaN | 250,000 |
| Lease impairment (gain on settlement) | 0 | NaN | NaN | 269,994 |
| Impairment on assets from manufacturing shut down | 0 | 1,422,289 | NaN | NaN |
| Change in deferred tax asset | NaN | NaN | NaN | 0 |
| Amortization of deferred financing costs | -1,748,299 | 953,618 | 794,681 | NaN |
| Stock-based compensation | 3,987,514 | 8,300,673 | 5,756,398 | 2,106,862 |
| Accounts receivable | -98,159 | 310,062 | 126,975 | 484,580 |
| Inventory | -513,036 | -307,407 | -117,190 | 470,188 |
| Prepaid expenses and other assets | -319,869 | -306,582 | 1,381,321 | -222,005 |
| Operating lease payable | -21,674 | 9,045 | -7,079 | 20,965 |
| Accounts payable and accrued liabilities | 231,128 | 639,755 | 2,204,991 | 2,865,251 |
| Deferred revenue | -44,963 | -4,060 | 38,192 | -222,100 |
| Net cash provided by operating activities - continuing operations | NaN | NaN | NaN | -8,423,042 |
| Net cash provided by (used in) operating activities - discontinued operations | NaN | NaN | NaN | 0 |
| Net cash used in operating activities | -4,776,643 | -2,681,666 | -9,780,221 | -8,423,042 |
| Proceeds from the sale of building | 0 | 0 | 0 | 4,005,516 |
| Proceeds from the sale of e-core | 0 | 0 | 0 | 2,000,000 |
| Proceeds from the sale of mw products assets | 0 | 175,000 | NaN | NaN |
| Proceeds from the sale of vitamedica, inc | 660,000 | NaN | NaN | 0 |
| Proceeds from the sale of interactive offers, net of liabilities paid | NaN | NaN | NaN | 0 |
| Acquisition of digital assets | 797,561 | 6,645,495 | 29,579,741 | 104,910,839 |
| Proceeds from the sale of digital assets | 8,030,609 | NaN | NaN | NaN |
| Acquisition of cygnet online llc, net | NaN | NaN | NaN | 0 |
| Investment in digital assets company | NaN | NaN | 750,000 | NaN |
| Acquisition of royalty interest | 0 | 750,000 | NaN | NaN |
| Acquisition of property and equipment | 11,724 | 17,451 | 14,827 | 387,760 |
| Net cash provided by (used in) investing activities - continuing operations | NaN | NaN | NaN | -99,293,083 |
| Net cash (used in) investing activities - discontinued operations | NaN | NaN | NaN | 0 |
| Net cash (used in) provided by investing activities | 7,881,324 | -6,487,946 | -30,344,568 | -99,293,083 |
| Proceeds from issuance of common stock | 7,467,302 | 10,000,000 | 50,000,000 | 92,556,053 |
| Payments of equity issuance costs | NaN | 3,743,654 | NaN | NaN |
| Issuance of preferred stock series a | 0 | NaN | NaN | 325,000 |
| Repurchases of common stock | NaN | 799,277 | NaN | NaN |
| Proceeds from exercise of pre-funded warrants | 7,889 | NaN | NaN | NaN |
| Repayment on note payable on building | NaN | 0 | 0 | -66,655 |
| Proceeds from exercise of warrants | 92,111 | 0 | 7,889 | 250,000 |
| Payment on convertible note | NaN | NaN | NaN | 150,000 |
| Repurchases of common stock | 2,773,959 | NaN | NaN | NaN |
| Proceeds from short-term treasury debt | 5,000,000 | NaN | NaN | 20,000,000 |
| Repayment of short-term treasury debt | 10,400,000 | NaN | NaN | NaN |
| Proceeds from issuance of convertible notes | 0 | NaN | NaN | 350,000 |
| Repayment of cygnet notes payable | 0 | NaN | NaN | 500,000 |
| Repayment of promissory notes | 560,000 | NaN | NaN | NaN |
| Repayment on note payable on building | 0 | NaN | NaN | NaN |
| Proceeds from exercise of warrants | NaN | 100,000 | NaN | NaN |
| Proceeds from related party advance | 0 | NaN | NaN | 75,000 |
| Repayment on note payable on building | NaN | NaN | NaN | 2,634,538 |
| Repayment of related party advance | 0 | 0 | 0 | 175,000 |
| Net cash used in financing activities - continuing operations | NaN | NaN | NaN | 110,029,860 |
| Payments of equity issuance costs | 1,522,788 | NaN | 2,992,085 | NaN |
| Net cash (used in) provided by financing activities - discontinued operations | NaN | NaN | NaN | 0 |
| Payments of debt issuance costs | 0 | 0 | 7,628,942 | NaN |
| Net cash provided by (used in) financing activities | -1,238,599 | 8,549,154 | 39,386,862 | 110,029,860 |
| Net increase (decrease) in cash | 1,866,082 | -620,458 | -737,927 | 2,313,735 |
| Effect of exchange rate changes on cash | NaN | NaN | NaN | 0 |
| Cash, beginning of period | 1,616,765 | 2,237,223 | 2,975,150 | 661,415 |
| Cash, end of period | 3,482,847 | 1,616,765 | 2,237,223 | 2,975,150 |
UPEXI, INC. (UPXI)
UPEXI, INC. (UPXI)